SQZ BIOTECHNOLOGIES CO
SQZ BIOTECHNOLOGIES CO logo
SQZ

SQZ BIOTECHNOLOGIES CO (SQZ)

$0.8233.24%

Market is closed
– opens on 8 PM, 06 Feb 2023
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.79
Day's Range
$0.859899
$0.6538
52-Week Range
$7.61
1 month return6.56%
3 month return70.5%
1 year return88.86%
5 year return93.79%

Analyst Recommendation

based on 10 analysts ratings

Buy
90%
Buy
10%
Hold
0%
Sell

Based on 10 Wall street analysts offering stock ratings for SQZ BIOTECHNOLOGIES CO(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 1601.09%

Current

$0.82

Target

$14.0

Recommendation Trend

Based on 10 analyst

Current1M Ago3M Ago
Buy
9
5
8
Hold
1
0
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization24.1M
Book Value$2.34
Dividend Share0.0
Dividend Yield0.0%
Earnings Per Share (EPS)-2.65
Wall Street Target Price14.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)0.5
Enterprise Value12.4M
Enterprise Value/Revenue0.58
Enterprise Value/Ebitda-0.18

Technicals

Beta2.78
50 Day MA1.13
200 Day MA2.6

Institutional Holdings

Temasek Holdings Ltd.

9.37%

American International Group Inc

8.55%

683 Capital Management LLC

7.62%

Artal Group S A

5.45%

NanoDimension, Inc.

4.91%

Maverick Capital Ltd

3.63%

Company Information

SQZ Biotechnologies is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ Biotechnologies offers the unique ability to deliver multiple materials into many patient cell types to engineer what SQZ Biotechnologies believes can be an unprecedented range of potential therapeutics for a variety of diseases. SQZ Biotechnologies has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and to improve the patient experience over existing cell therapy approaches. With accelerated production timelines under 24 hours and the opportunity to eliminate preconditioning and lengthy hospital stays, its goal is to use the SQZ approach to establish a new paradigm for cell therapies. The Company's first therapeutic applications aim to leverage the potential to generate target-specific immune responses, both in activation for the treatment of solid tumors and immune tolerance for the treatment of unwanted immune reactions and autoimmune diseases.
OrganizationSQZ BIOTECHNOLOGIES CO
Employees113
CEODr. Howard Bernstein M.D., Ph.D.
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is SQZ BIOTECHNOLOGIES CO share price today?

Can Indians buy SQZ BIOTECHNOLOGIES CO shares?

How can I buy SQZ BIOTECHNOLOGIES CO shares from India?

Can Fractional shares of SQZ BIOTECHNOLOGIES CO be purchased?

What are the documents required to start investing in SQZ BIOTECHNOLOGIES CO stocks?

What are today’s High and Low prices of SQZ BIOTECHNOLOGIES CO?

What are today’s traded volumes of SQZ BIOTECHNOLOGIES CO?

What is today’s market capitalisation of SQZ BIOTECHNOLOGIES CO?

What is the 52 Week High and Low Range of SQZ BIOTECHNOLOGIES CO?

How much percentage SQZ BIOTECHNOLOGIES CO is down from its 52 Week High?

How much percentage SQZ BIOTECHNOLOGIES CO is up from its 52 Week low?

What are the historical returns of SQZ BIOTECHNOLOGIES CO?

Who is the Chief Executive Officer (CEO) of SQZ BIOTECHNOLOGIES CO?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*